CollPlant Biotechnologies (CLGN) Beginning Cash Balance (2019 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Beginning Cash Balance came in at $13.4 million in Q1 2022, up 279.3% YoY from $3.5 million in Q1 2021, and up 279.3% on a QoQ basis from $3.5 million in Q1 2021.
CollPlant Biotechnologies (CLGN) Beginning Cash Balance (2019 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 4 years of Beginning Cash Balance data on file, last reported at $13.4 million in Q1 2022.
- Quarterly Beginning Cash Balance rose 279.3% year-over-year to $13.4 million in Q1 2022, while the trailing twelve-month figure through Dec 2024 was $13.4 million (changed N/A YoY) and the FY2025 annual result came in at $11.9 million, down 55.35% from the prior year.
- Beginning Cash Balance advanced to $13.4 million in Q1 2022, from $3.5 million in the prior quarter.
- In the past five years, Beginning Cash Balance ranged from a high of $13.4 million in Q1 2022 to a low of $3.5 million in Q1 2021.
- A 4-year average of $6.6 million and a median of $4.8 million in 2019 frame the typical range for Beginning Cash Balance.
- Annual changes were most pronounced in 2020 — Beginning Cash Balance slipped 29.88% — and 2022, when it jumped 279.3%.
- Tracing CLGN's Beginning Cash Balance over 4 years: stood at $5.7 million in 2019, then fell by 29.88% to $4.0 million in 2020, then retreated by 11.21% to $3.5 million in 2021, then jumped by 279.3% to $13.4 million in 2022.
- The last three Beginning Cash Balance figures came in at $13.4 million (Q1 2022), $3.5 million (Q1 2021), and $4.0 million (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.91 Mn |
| Dec 31, 2025 | 11.91 Mn |
| Sep 30, 2025 | 11.91 Mn |
| Sep 30, 2025 | 11.91 Mn |
| Jun 30, 2025 | 11.91 Mn |
| Jun 30, 2025 | 11.91 Mn |
| Dec 31, 2024 | 26.67 Mn |
| Dec 31, 2024 | 26.67 Mn |
| Sep 30, 2024 | 26.67 Mn |
| Sep 30, 2024 | 26.67 Mn |
| Jun 30, 2024 | 26.67 Mn |
| Jun 30, 2024 | 26.67 Mn |
| Dec 31, 2023 | 29.86 Mn |
| Dec 31, 2023 | 29.86 Mn |
| Dec 31, 2022 | 13.37 Mn |
| Dec 31, 2022 | 13.37 Mn |
| Jun 30, 2022 | 13.37 Mn |
| Jun 30, 2022 | 13.37 Mn |
| Mar 31, 2022 | 13.37 Mn |
| Mar 31, 2022 | 13.37 Mn |